Robert W. Duggan - 11 Dec 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
Issuer symbol
PLSE
Transactions as of
11 Dec 2023
Net transactions value
+$843,504
Form type
4
Filing time
13 Dec 2023, 18:03:07 UTC
Previous filing
12 Dec 2023
Next filing
14 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $843,504 +90,118 +0.24% $9.36 36,966,180 11 Dec 2023 Direct F1
holding PLSE Common Stock 351,565 11 Dec 2023 See footnote F2
holding PLSE Common Stock 492,069 11 Dec 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Volume-weighted average price.
F2 Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.
F3 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.